GMED

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Globus Medical Inc

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders.
CEO
David Demski
Employees
2200
Headquarters

2560 General Armistead Ave
Audubon, Pennsylvania 19403-5214
Phone: 16109301800
www.globusmedical.com

News

Globus Medical (GMED) Q4 2022 Earnings Call Transcript
Feb 22, 2023 03:00am

GMED earnings call for the period ending December 31, 2022.


Source:The Motley Fool
Globus Medical, Inc. (GMED) Q4 2022 Earnings Call Transcript
Feb 22, 2023 01:05am

Globus Medical, Inc. (NYSE:NYSE:GMED) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ETCompany ParticipantsBrian Kearns - Senior Vice President of Business Development and…


Source:Seeking Alpha
Globus Medical Non-GAAP EPS of $0.59 beats by $0.03, revenue of $274.5M misses by $1.9M, guidance below consensus
Feb 21, 2023 21:25pm

Globus Medical press release (GMED): Q4 Non-GAAP EPS of $0.59 beats by $0.03.Revenue of $274.5M (+9.8% Y/Y) misses by $1.9M.,The Company today announced full year stand-alone…


Source:Seeking Alpha
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
Feb 21, 2023 21:15pm

AUDUBON, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022.


Source:GlobeNewswire
Globus Medical Q4 2022 Earnings Preview
Feb 20, 2023 22:35pm

Globus Medical (GMED) is scheduled to announce Q4 earnings results on Tuesday, February 21st, after market close.The consensus EPS Estimate is $0.56 (+14.3% Y/Y) and the consensus…


Source:Seeking Alpha
Globus Medical Earnings Preview
Feb 20, 2023 18:00pm

Globus Medical (NYSE: GMED ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-21. Here''s what investors need to know before the announcement. Analysts estimate that Globus Medical will report an earnings per share (EPS) of $0.56. Globus Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com


Source:Benzinga
Globus Medical Inc. (NYSE: GMED) -1.41% Decline Turns Investors Off From Company Stock
Feb 14, 2023 13:30pm

Globus Medical Inc. (NYSE:GMED) traded at $59.43 at close of the session on Monday, 02/13/23, made a downward move of -1.41% on its previous day’s price. Looking at the stock we see that its previous close was $60.28 and the beta (5Y monthly) reads 1.04 with the day’s price range being $58.98 – $60.55. The … Globus Medical Inc. (NYSE: GMED) -1.41% Decline Turns Investors Off From Company Stock Read More »


Source:Stocks Register
BofA Securities Downgrades Globus Medical to Underperform
Feb 13, 2023 13:54pm

https://www.investing.com/news/pro/bofa-securities-downgrades-globus-medical-to-underperform-432SI-3001849


Source:Investing.com
Globus Medical: Does The NuVasive Merger Make Sense? (NYSE:GMED)
Feb 13, 2023 04:21am

Globus Medical announced a merger with NuVasive on February 8. Find out should the retail investors of GMED and NUVA buy, hold, or sell their shares.


Source:Seeking Alpha
Globus Medical Stock: Back Pains (NYSE:GMED)
Feb 12, 2023 14:49pm

Globus Medical is a producer of musculoskeletal implants used for patients who suffer from spine disorders. Click here to read my analysis of GMED stock.


Source:Seeking Alpha
Globus And NuVasive Take Spinal Fusion To A New Level (NYSE:GMED)
Feb 12, 2023 10:11am

Globus and NuVasive''s merger deal will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share. Read what investors need to know.


Source:Seeking Alpha
What will the future hold for Globus Medical Inc. (NYSE:GMED) stock?
Feb 10, 2023 18:16pm

Currently, Globus Medical Inc.’s (GMED) stock is trading at $61.06, marking a fall of -3.03% from last night’s close. At this price, the stock is -25.34% below its 52-week high of $81.78 and 16.08% above its 52-week low of $52.60. Based on the past 30-day period, the stock price is -24.34% below the high and […]


Source:US Post News
Needham & Company Downgrades Globus Medical to Hold
Feb 10, 2023 10:41am

https://www.investing.com/news/pro/needham--company-downgrades-globus-medical-to-hold-432SI-3000347


Source:Investing.com
Truist Securities Downgrades Globus Medical to Hold
Feb 10, 2023 08:26am

https://www.investing.com/news/pro/truist-securities-downgrades-globus-medical-to-hold-432SI-3000211


Source:Investing.com
That Will Motivate You Today: Warner Bros. Discovery, Inc. (NASDAQ:WBD -1.30%), Globus Medical, Inc. (NYSE:GMED -18.18%)
Feb 10, 2023 04:41am

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post That Will Motivate You Today: Warner Bros. Discovery, Inc. (NASDAQ:WBD -1.30%), Globus Medical, Inc. (NYSE:GMED -18.18%) appeared first on Stocks Equity .


Source:Stock Equity
San Diego spine surgery firm NuVasive acquired by rival Globus Medical in $3.1B deal
Feb 10, 2023 01:54am

Companies contend there is little overlap, which opens the door for cross-selling products and services in the competitive spine surgery technology market.


Source:San Diego Union-Tribune
Globus Medical(GMED.US)30(NUVA.US) 18%
Feb 10, 2023 01:35am

Globus Medical(GMED.US)拟以30亿美元收购纽瓦索器材(NUVA.US) 股价暴跌18%


Source:Investing.com China
Globus Medical’s $3 bln deal for NuVasive to fortify spinal business spooks investors
Feb 09, 2023 18:46pm

Globus Medical Inc said on Thursday it would acquire peer NuVasive Inc in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices. NuVasive shareholders will receive 0.75 of Globus shares, implying a per-share offer of $57.72 and a premium of about 26% to Wednesday’s close. Shares […]


Source:Financial Post
Globus Medical''s $3 bln deal for NuVasive to fortify spinal business spooks investors
Feb 09, 2023 18:45pm

Globus Medical Inc said on Thursday it would acquire peer NuVasive Inc in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices.


Source:Reuters
Shareholder Alert: Ademi LLP investigates whether NuVasive, Inc. has obtained a Fair Price in its transaction with Globus Medical
Feb 09, 2023 16:15pm

MILWAUKEE, Feb. 9, 2023 /PRNewswire/ -- Ademi LLP is investigating NuVasive (NASDAQ: NUVA) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical. Click here to learn how to join the action https://www.ademilaw.com/case/nuvasive-inc or…


Source:PR Newswire
Globus Medical downgraded at Piper with a `bunch of challenges'' with Nuvasive deal
Feb 09, 2023 15:20pm

Globus Medical (GMED) was cut to neutral from overweight at Piper Sandler after agreeing to acquire Nuvasive Medical in more than $3 billion all stock deal


Source:Seeking Alpha
GMED Tanks on NuVasive Deal
Feb 09, 2023 14:41pm

Shares of medical devices provider Globus Medical (NYSE:GMED) are tanking today after the company announced an all-stock combination with NuVasive …


Source:TipRanks
Spine Implants Global Market Report 2023
Feb 08, 2023 16:03pm

Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical.


Source:GlobeNewswire
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
Feb 02, 2023 21:30pm

AUDUBON, Pa., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com .


Source:GlobeNewswire
Ukrainian physicians on the frontline amongst 900 presenters at the 20th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT) in LA
Feb 01, 2023 23:38pm


Source:Kwhen Finance